Olema Pharmaceuticals, Inc. (OLMA)
6.58
-0.29
(-4.22%)
USD |
NASDAQ |
Oct 16, 16:00
6.58
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Cash and Short Term Investments (Quarterly) : 461.07M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 461.07M |
| March 31, 2026 | 505.35M |
| December 31, 2025 | 505.44M |
| September 30, 2025 | 328.96M |
| June 30, 2025 | 361.91M |
| March 31, 2025 | 392.71M |
| December 31, 2024 | 434.09M |
| September 30, 2024 | 214.76M |
| June 30, 2024 | 239.10M |
| March 31, 2024 | 248.98M |
| December 31, 2023 | 261.81M |
| September 30, 2023 | 276.90M |
| Date | Value |
|---|---|
| June 30, 2023 | 167.44M |
| March 31, 2023 | 185.95M |
| December 31, 2022 | 204.42M |
| September 30, 2022 | 222.60M |
| June 30, 2022 | 240.71M |
| March 31, 2022 | 267.87M |
| December 31, 2021 | 287.25M |
| September 30, 2021 | 305.95M |
| June 30, 2021 | 318.14M |
| March 31, 2021 | 326.97M |
| December 31, 2020 | 338.55M |
| September 30, 2020 | 127.82M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 138.44M |
| Puma Biotechnology, Inc. | 93.90M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |